Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use?

Journal of Pain and Symptom Management

Volumn 36, Issue 4, 2008, Pages 424-441

  Newton, Phillip J ^b,c   Davidson, Patricia M ^c   Macdonald, Peter ^d,e   Ollerton, Richard ^a   Krum, Henry ^f,g  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g ALFRED HOSPITAL   (Australia)

Author keywords

acute disease; chronic disease; drug administration; dyspnea; Furosemide; inhalation

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; ALLERGEN; AMILORIDE; AMINOPHYLLINE; BECLOMETASONE; BUMETANIDE; ETACRYNIC ACID; FLURBIPROFEN; FUROSEMIDE; HYDROCORTISONE; INDOMETACIN; IPRATROPIUM BROMIDE; MACROGOL; MORPHINE; ORCIPRENALINE; PIRETANIDE; PLACEBO; SALBUTAMOL; STEROID; TORASEMIDE; TROMETAMOL;

ABSENCE OF SIDE EFFECTS; ASTHMA; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; COUGHING; DIURESIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HEALTH HAZARD; HUMAN; HYPERVENTILATION; MONOTHERAPY; NAUSEA; OXYGEN THERAPY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SPIROMETRY; SPUTUM; UPPER AIRWAY IRRITATION; VISUAL ANALOG SCALE;

ADMINISTRATION, INHALATION; CLINICAL TRIALS AS TOPIC; DYSPNEA; EVIDENCE-BASED MEDICINE; FUROSEMIDE; HUMANS; NEBULIZERS AND VAPORIZERS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 52049091876     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2007.10.017     Document Type: Review

References (56)

1. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 159 1 (1999) 321-340
2. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure). Circulation 104 24 (2001) 2996-3007
3. Bianco S., Vaghi A., Robuschi M., and Pasargiklian M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet 2 8605 (1988) 252-255
4. Jackson E.K. Diuretics. In: Brunton L., Lazo J.S., and Parker K.L. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics (2006), McGraw-Hill, New York, NY 737-770
5. Shankar S.S., and Brater D.C. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 284 1 (2003) F11-F21
6. O'Donnell W.J., and Israel E. Inhaled diuretics in asthma: the search for the mechanism of action. J Asthma 31 2 (1994) 79-83
7. Cavaliere F., and Masieri S. Furosemide protective effect against airway obstruction. Curr Drug Targets 3 3 (2002) 197-201
8. Lockhart A., and Slutsky A.S. Furosemide and loop diuretics in human asthma. Chest 106 1 (1994) 244-249
9. Elwood W., Lotvall J.O., Barnes P.J., and Chung K.F. Loop diuretics inhibit cholinergic and noncholinergic nerves in guinea pig airways. Am Rev Respir Dis 143 6 (1991) 1340-1344
10. Verleden G.M., Pype J.L., Deneffe G., and Demedts M.G. Effect of loop diuretics on cholinergic neurotransmission in human airways in vitro. Thorax 49 7 (1994) 657-663
11. Corboz M.R., Ballard S.T., Gao H., et al. Differential effects of furosemide on porcine bronchial arterial and airway smooth muscle. J Appl Physiol 89 4 (2000) 1360-1364
12. Freed A.N., Taskar V., Schofield B., and Omori C. Effect of furosemide on hyperpnea-induced airway obstruction, injury, and microvascular leakage. J Appl Physiol 81 6 (1996) 2461-2467
13. Gilbert I.A., Lenner K.A., Nelson J.A., Wolin A.D., and Fouke J.M. Inhaled furosemide attenuates hyperpnea-induced obstruction and intra-airway thermal gradients. J Appl Physiol 76 1 (1994) 409-415
14. Lundergan C.F., Fitzpatrick T.M., Rose J.C., Ramwell P.W., and Kot P.A. Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. J Pharmacol Exp Ther 246 1 (1988) 102-106
15. Sudo T., Hayashi F., and Nishino T. Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats. Am J Respir Crit Care Med 162 3 Pt 1 (2000) 971-975
16. Tanigaki T., Kondo T., Hayashi Y., et al. Rapid response to inhaled frusemide in severe acute asthma with hypercapnia. Respiration 64 1 (1997) 108-110
17. Ono Y., Kondo T., Tanigaki T., and Ohta Y. Furosemide given by inhalation ameliorates acute exacerbation of asthma. J Asthma 34 4 (1997) 283-289
18. Rodriguez Vazquez J.C., Pino Alfonso P.P., Gassiot Nuno C., Paez Prats I., and Fernandez Manzano E. Assessment of the bronchodilator effect of inhaled furosemide compared to salbutamol in asthmatic patients. J Investig Allergol Clin Immunol 8 2 (1998) 115-118
19. Pendino J.C., Nannini L.J., Chapman K.R., Slutsky A., and Molfino N.A. Effect of inhaled furosemide in acute asthma. J Asthma 35 1 (1998) 89-93
20. Karpel J.P., Dworkin F., Hager D., et al. Inhaled furosemide is not effective in acute asthma. Chest 106 5 (1994) 1396-1400
21. Polosa R., Lau L.C., and Holgate S.T. Inhibition of adenosine 5'-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J 3 6 (1990) 665-672
22. Rajakulasingam K., Polosa R., Church M.K., Howarth P.H., and Holgate S.T. Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma. Thorax 49 5 (1994) 485-491
23. Polosa R., Rajakulasingam K., Prosperini G., Church M.K., and Holgate S.T. Relative potencies and time course of changes in adenosine 5'-monophosphate airway responsiveness with inhaled furosemide and bumetanide in asthma. J Allergy Clin Immunol 92 2 (1993) 288-297
24. Moscato G., Dellabianca A., Falagiani P., et al. Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic "fog" of distilled water in asthmatics. Am Rev Respir Dis 143 3 (1991) 561-566
25. Foresi A., Pelucchi A., Mastropasqua B., et al. Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects. Am Rev Respir Dis 146 2 (1992) 364-368
26. Robuschi M., Gambaro G., Spagnotto S., Vaghi A., and Bianco S. Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulm Pharmacol 1 4 (1989) 187-191
27. Nichol G.M., Alton E.Q., Nix A., et al. Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis 142 3 (1990) 576-580
28. O'Connor B.J., Chung K.F., Chen-Worsdell Y.M., Fuller R.W., and Barnes P.J. Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 143 6 (1991) 1329-1333
29. Yeo C.T., O'Connor B.J., Chen-Worsdell M., Barnes P.J., and Chung K.F. Protective effect of loop diuretics, piretanide and frusemide, against sodium metabisulphite-induced bronchoconstriction in asthma. Eur Respir J 5 10 (1992) 1184-1188
30. O'Connor B.J., Barnes P.J., and Chung K.F. Inhibition of sodium metabisulphite induced bronchoconstriction by frusemide in asthma: role of cyclooxygenase products. Thorax 49 4 (1994) 307-311
31. Pye S., Pavord I., Wilding P., et al. A comparison of the effects of inhaled furosemide and ethacrynic acid on sodium-metabisulfite-induced bronchoconstriction in subjects with asthma. Am J Respir Crit Care Med 151 2 Pt 1 (1995) 337-339
32. Pavord I.D., Wisniewski A., and Tattersfield A.E. Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax 47 10 (1992) 797-800
33. Robuschi M., Pieroni M., Refini M., et al. Prevention of antigen-induced early obstructive reaction by inhaled furosemide in (atopic) subjects with asthma and (actively sensitized) guinea pigs. J Allergy Clin Immunol 85 1 Pt 1 (1990) 10-16
34. Bianco S., Pieroni M.G., Refini R.M., Rottoli L., and Sestini P. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med 321 6 (1989) 1069-1073
35. Daviskas E., Anderson S.D., Gonda I., et al. Mucociliary clearance during and after isocapnic hyperventilation with dry air in the presence of frusemide. Eur Respir J 9 4 (1996) 716-724
36. Rodwell L.T., Anderson S.D., du Toit J., and Seale J.P. Different effects of inhaled amiloride and frusemide on airway responsiveness to dry air challenge in asthmatic subjects. Eur Respir J 6 6 (1993) 855-861
37. Sestini P., Pieroni M.G., Refini R.M., et al. Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics. Eur Respir J 7 10 (1994) 1825-1829
38. Vargas F.S., Croce M., Teixeira L.R., et al. Effect of inhaled furosemide on the bronchial response to lysine-aspirin inhalation in asthmatic subjects. Chest 102 2 (1992) 408-411
39. Polosa R., Rajakulasingam K., Prosperini G., et al. Inhaled loop diuretics and basal airway responsiveness in man: evidence of a role for cyclo-oxygenase products. Eur Respir J 8 4 (1995) 593-599
40. Kohara H., Ueoka H., Aoe K., et al. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. J Pain Symptom Manage 26 4 (2003) 962-967
41. Shimoyama N., and Shimoyama M. Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients. J Pain Symptom Manage 23 1 (2002) 73-76
42. Ong K.-C., Kor A.-C., Chong W.-F., Earnest A., and Wang Y.-T. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169 9 (2004) 1028-1033
43. Ventresca P.G., Nichol G.M., Barnes P.J., and Chung K.F. Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. Am Rev Respir Dis 142 1 (1990) 143-146
44. 2 ventilatory responsiveness in humans. Pulm Pharmacol Ther 154 4 (2002) 363-368
45. Nishino T., Ide T., Sudo T., and Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 161 6 (2000) 1963-1967
46. Yates D.H., O'Connor B.J., Yilmaz G., et al. Effect of acute and chronic inhaled furosemide on bronchial hyperresponsiveness in mild asthma. Am J Respir Crit Care Med 152 6 Pt 1 (1995) 2173-2175
47. Rodriguez Vazquez J.C., Pino Alfonso P.P., Gassiot Nuno C., and Paez Prats I. Usefulness of inhaled furosemide in a bronchial asthma attack. J Investig Allergol Clin Immunol 8 5 (1998) 290-293
48. Bianco S., Vaghi A., Robuschi M., et al. Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma. J Allergy Clin Immunol 95 5 Pt 1 (1995) 937-943
49. Wolkove N., Dajczman E., Colacone A., and Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 96 6 (1989) 1247-1251
50. Rodwell L.T., Anderson S.D., du Toit J.I., and Seale J.P. The effect of inhaled frusemide on airway sensitivity to inhaled 4.5% sodium chloride aerosol in asthmatic subjects. Thorax 48 3 (1993) 208-213
51. Feather I.R., and Olson L.G. Frusemide antagonises exercise-induced but not histamine-induced bronchospasm. Aust N Z J Med 21 1 (1991) 7-10
52. Crimi N., Prosperini G., Ciamarra I., et al. Changes in neurokinin A (NKA) airway responsiveness with inhaled frusemide in asthma. Thorax 52 9 (1997) 775-779
53. Echazarreta A.L., Gomez F.P., Ribas J., et al. Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma. Eur Respir J 14 3 (1999) 616-621
54. Bellingan G.J., Dixon C.M., and Ind P.W. Inhibition of inhaled metabisulphite-induced bronchoconstriction by inhaled frusemide and ipratropium bromide. Br J Clin Pharmacol 34 1 (1992) 71-74
55. Hasani A., Pavia D., Spiteri M.A., et al. Inhaled frusemide does not affect lung mucociliary clearance in healthy and asthmatic subjects. Eur Respir J 7 8 (1994) 1497-1500
56. Stone R.A., Barnes P.J., and Chung K.F. Effect of frusemide on cough responses to chloride-deficient solution in normal and mild asthmatic subjects. Eur Respir J 6 6 (1993) 862-867